The genetic evolution of acral melanoma
Meng Wang,
Satoshi Fukushima,
Yi-Shuan Sheen,
Egle Ramelyte,
Noel Cruz-Pacheco,
Chenxu Shi,
Shanshan Liu,
Ishani Banik,
Jamie D. Aquino,
Martin Sangueza Acosta,
Mitchell Levesque,
Reinhard Dummer,
Jau-Yu Liau,
Chia-Yu Chu,
A. Hunter Shain,
Iwei Yeh and
Boris C. Bastian ()
Additional contact information
Meng Wang: University of California San Francisco
Satoshi Fukushima: Kumamoto University
Yi-Shuan Sheen: National Taiwan University Hospital and National Taiwan University College of Medicine
Egle Ramelyte: University of Zurich
Noel Cruz-Pacheco: University of California San Francisco
Chenxu Shi: University of California San Francisco
Shanshan Liu: University of California San Francisco
Ishani Banik: University of California San Francisco
Jamie D. Aquino: University of California San Francisco
Martin Sangueza Acosta: Caja Nacional de Salud
Mitchell Levesque: University of Zurich
Reinhard Dummer: University of Zurich
Jau-Yu Liau: National Taiwan University Hospital and National Taiwan University College of Medicine
Chia-Yu Chu: National Taiwan University Hospital and National Taiwan University College of Medicine
A. Hunter Shain: University of California San Francisco
Iwei Yeh: University of California San Francisco
Boris C. Bastian: University of California San Francisco
Nature Communications, 2024, vol. 15, issue 1, 1-13
Abstract:
Abstract Acral melanoma is an aggressive type of melanoma with unknown origins. It is the most common type of melanoma in individuals with dark skin and is notoriously challenging to treat. We examine exome sequencing data of 139 tissue samples, spanning different progression stages, from 37 patients. We find that 78.4% of the melanomas display clustered copy number transitions with focal amplifications, recurring predominantly on chromosomes 5, 11, 12, and 22. These complex genomic aberrations are typically shared across all progression stages of individual patients. TERT activating alterations also arise early, whereas MAP-kinase pathway mutations appear later, an inverted order compared to the canonical evolution. The punctuated formation of complex aberrations and early TERT activation suggest a unique mutational mechanism that initiates acral melanoma. The marked intratumoral heterogeneity, especially concerning MAP-kinase pathway mutations, may partly explain the limited success of therapies for this melanoma subtype.
Date: 2024
References: View references in EconPapers View complete reference list from CitEc
Citations:
Downloads: (external link)
https://www.nature.com/articles/s41467-024-50233-z Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-50233-z
Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/
DOI: 10.1038/s41467-024-50233-z
Access Statistics for this article
Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie
More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().